Eu Ivdr Eu Ivd Class B On The Market

IDS Deamidated Gliadin IgA

Devices (same UDI-DI)
1
Certificates
0
Countries
32
Notified Bodies
0

Let the assistant research this device

The Research Assistant compiles risk class, certificates, notified bodies and related records — and cites every one.

Free to try · every answer cites its records

Basic Information

Primary DI
05060169694149
Basic UDI-DI Code
5060169694149XS
Reference
IS-AI1301
Device Types
None provided
Regulation
Eu Ivdr
Classification
Eu Ivd Class B
Status
On The Market

Additional Description

The IDS Deamidated Gliadin IgA test is an automated in vitro diagnostic device intended for the quantitative determination of specific IgA antibodies directed against deamidated gliadin peptides (anti-DGP IgA) in samples of human serum or plasma (EDTA, heparin) on the IDS System. Results are to be used in conjunction with other clinical and laboratory data to assist the clinician as an aid in the evaluation of systemic of gluten enteropathy (celiac disease - CD) and dermatitis herpetiformis (Durhing’s disease).

CND Nomenclature Codes

Code Description
W0102100604 GLIADIN ANTIBODIES

Available In Countries

🇦🇹 Austria 🇧🇪 Belgium 🇧🇬 Bulgaria 🇨🇾 Cyprus 🇨🇿 Czechia 🇩🇪 Germany 🇩🇰 Denmark 🇪🇪 Estonia 🇬🇷 Greece 🇪🇸 Spain 🇫🇮 Finland 🇫🇷 France 🇭🇷 Croatia 🇭🇺 Hungary 🇮🇪 Ireland 🇮🇸 Iceland 🇮🇹 Italy 🇱🇮 Liechtenstein 🇱🇹 Lithuania 🇱🇺 Luxembourg 🇱🇻 Latvia 🇲🇹 Malta 🇳🇱 Netherlands 🇳🇴 Norway 🇵🇱 Poland 🇵🇹 Portugal 🇷🇴 Romania 🇸🇪 Sweden 🇸🇮 Slovenia 🇸🇰 Slovakia 🇹🇷 Türkiye 🇬🇧 United Kingdom

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Class B) and regulation (EU IVDR).

View all